Study of more than 10,000 US adults finds depression accounts for 21% of the relationship between stomach illness and sleep disturbances, suggesting need for integrated treatment approaches
Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates
KFF Health News
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.
Researchers link increased screen time in children and adolescents to higher cardiometabolic and cardiovascular risk, with sleep duration identified as a key moderating factor.